SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-000209
Filing Date
2024-01-03
Accepted
2024-01-03 09:10:10
Documents
20
Period of Report
2024-01-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 58380
2 ex4-1.htm EX-4.1 435474
3 ex5-1.htm EX-5.1 13562
4 ex4-1_001.jpg GRAPHIC 26954
5 ex4-1_002.jpg GRAPHIC 28331
6 ex4-1_003.jpg GRAPHIC 21401
7 ex4-1_004.jpg GRAPHIC 21967
8 ex4-1_005.jpg GRAPHIC 20895
9 ex5-1_001.jpg GRAPHIC 2216
  Complete submission text file 0001493152-24-000209.txt   919023

Data Files

Seq Description Document Type Size
10 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sava-20240103.xsd EX-101.SCH 3036
11 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sava-20240103_lab.xml EX-101.LAB 34240
12 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sava-20240103_pre.xml EX-101.PRE 22373
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3428
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29959 | Film No.: 24504506
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)